" "

Healthcare diagnostics startup Neuranics raises $700,000 led by Inflection Point Ventures

author-image
Vivek Vishwakarma
New Update
(L-R) Ashutosh Patra (Co-founder & CTO), Praveen Kumar (Co-founder & CEO) Neuranics

(L-R) Ashutosh Patra (Co-founder & CTO), Praveen Kumar (Co-founder & CEO) Neuranics

Neuranics, a healthcare diagnostics startup, has raised $700,000 in a seed funding round led by Inflection Point Ventures (IPV), a Gurugram-based angel investment firm.

The startup plans to use the raised capital for technology development and clinical validation to accelerate its mission to revolutionize blood diagnostics.

Developing a point-of-care blood analyzer

Founded in 2021 by Praveen Kumar (Co-founder & CEO) and Ashutosh Patra (Co-founder & CTO), Neuranics is developing a point-of-care blood analyzer capable of delivering complete blood count (CBC) results in less than 10 minutes using a finger-prick sample. 

Advertisment

The startup said that the device is designed for primary and emergency settings. It offers low maintenance and high efficiency, making it a game-changer for the healthcare industry.

"Our point-of-care CBC analyzer represents a significant leap forward in diagnostic convenience and accessibility. By utilizing a simple finger-prick capillary blood sample. We have effectively eliminated the need for traditional venipuncture, making blood testing faster, less invasive, and more patient-friendly," said Dr Megha Sharma, MD Pathologist and Chief Medical Evangelist at Neuranics," said Dr Megha Sharma, MD Pathologist and Chief Medical Evangelist at Neuranics.

Neuranics is supported by top life science institutes in the country, such as AIC-CCMB Hyderabad, Venture Centre Pune, and IHub-Anubhuti, and also supported by the School of International Biodesign, Dept of Biotechnology, GOI.

Leadership comments

Praveen Kumar, Co-founder & CEO of Neuranics, said, “We are re-imagining how we approach diagnostics by bringing instant, accurate blood analysis closer to the patient without compromising on the quality. Our technology empowers clinicians with real-time data, transforming care delivery and elevating patient outcomes. By leveraging AI on de-identified pathological imaging data generated by our analyzer, we aim to set a new gold standard for national screening programs."

"This innovative technology will elevate healthcare quality in India and establish the country as a global leader in point of care blood analyser. We thank IPV for being with us in this journey. Working with IPV has been a streamlined and transformative experience. Their investment and guidance have empowered us to scale faster, innovate further, and bring our vision to life. IPV's efficient processes and industry connections have been instrumental in our journey," Kumar added.

Mitesh Shah, Co-founder of IPV, said, “Neuranics is tackling the problem of lengthy and complex blood testing processes with their point-of-care blood analyzer that makes complete blood count diagnosis faster and easier. This significantly improves patient care, especially in urgent cases. IPV believes in the startups innovative technology and envisions a future where the startups bring out more such necessary tools”.

Subscribe